Nature's Sunshine Products Inc. Common Stock (NATR)

FairStock Score: 57/100 — STEADY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I start with the business. Nature's Sunshine sells vitamins, nutritional supplements, and personal-care products internationally, with 806 employees. It is a consumer-defensive firm, but supplements are competitive and brand loyalty is not always deep, so I see only a modest moat. The financials are more interesting. In fiscal 2025, the year ended 2025-12-31, revenue was $480.1M and net income $19.5M, or $1.06 per diluted share. That was a big improvement from fiscal 2024, when revenue was $454.4M and net income $7.7M, or $0.40 per share. Free cash flow over the trailing twelve months was $18.1M, an 8.1% yield on the $224.5M market cap. The balance sheet looks conservative: debt-to-equity is 0.13 and the Altman Z-Score is 2.98. At the close on 2026-10-13, the price was $12.76. FairStock calculations show a P/E of 12.76, P/B of 1.33, EV/EBITDA of 3.87, and a Graham Number of $14.70, giving a 13.2% margin of safety. That is not expensive. But the latest quarter gives pause: in fiscal Q2 2026, the quarter ended 2026-06-30, revenue was $117.0M, net income $3.5M, and diluted EPS $0.19, down from $5.3M and $0.28 in fiscal Q2 2025 despite slightly higher revenue. ROCE is 7.12%, Piotroski is 5/9, and FairStock labels it a TURNAROUND. Cheap yes, but I want evidence that margins and returns are durable before calling it a bargain.

In plain English: Nature's Sunshine sells nutritional supplements and personal-care products around the world. The company is profitable, carries little debt, and produces cash, but sales growth is modest and its latest quarter showed lower profit than a year earlier. At the recent price of $12.76, the stock looks somewhat cheap against the company's reported earnings and cash flow, though it has traded much higher in the past year.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer